Drug-Coated Balloon for Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials

Published: 15 September 2021| Version 2 | DOI: 10.17632/7jfhpxtpww.2
Yuxuan Zhang,


Our research hypothesis that DCB might be a feasible interventional strategy in treatment of patients with Acute Myocardial Infarction (AMI). Our data shows that DCB might be a feasible interventional strategy versus control as it associated with comparable clinical outcomes in the treatment of AMI. Future large-volume, well-designed randomized controlled trials to evaluating the role of the DCB in this setting are warranted. All data in this research, including major adverse cardiac events (MACEs); target lesion revascularization (TLR); myocardial infarction (MI); cardiovascular mortality; all-cause mortality; stent thrombosis; minimum lumen diameter (MLD) and late lumen loss (LLL), was come from other articles. You can get those data through this research or the articles which this research included.